Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study

Gary Tse; Sharen Lee; Tong Liu; Jiandong Zhou

doi:10.1007/s10557-024-07550-8

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study

Gary Tse, Sharen Lee, Tong Liu, Jiandong Zhou

Health Sciences

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	391-392
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	38
Issue number	2
DOIs	https://doi.org/10.1007/s10557-024-07550-8
Publication status	Published - Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s10557-024-07550-8

Cite this

@article{6b9e2ca9fbd44b279b28a55ceb8890ea,

title = "Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study",

author = "Gary Tse and Sharen Lee and Tong Liu and Jiandong Zhou",

year = "2024",

month = apr,

doi = "10.1007/s10557-024-07550-8",

language = "English",

volume = "38",

pages = "391--392",

number = "2",

}

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study. / Tse, Gary; Lee, Sharen; Liu, Tong et al.
In: Cardiovascular Drugs and Therapy, Vol. 38, No. 2, 04.2024, p. 391-392.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors

T2 - The Hong Kong Diabetes Study

AU - Tse, Gary

AU - Lee, Sharen

AU - Liu, Tong

AU - Zhou, Jiandong

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85182666069&partnerID=8YFLogxK

U2 - 10.1007/s10557-024-07550-8

DO - 10.1007/s10557-024-07550-8

M3 - Letter

C2 - 38244149

AN - SCOPUS:85182666069

SN - 0920-3206

VL - 38

SP - 391

EP - 392

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

IS - 2

ER -

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors: The Hong Kong Diabetes Study

UN SDGs

Access to Document

Other files and links

Cite this